Home › FDA Approves The Patheon Site In Bourgoin, France To Manufacture Drugs For U.S. Market
 

Keywords :   


FDA Approves The Patheon Site In Bourgoin, France To Manufacture Drugs For U.S. Market

2014-05-09 16:12:50| drugdiscoveryonline News Articles

Patheon , the pharmaceutical services business owned by DPx Holdings, recently received FDA approval for its Bourgoin, France site to begin manufacturing and selling drugs to the U.S. market. The Bourgoin site specializes in development and commercial scale manufacture of solid oral forms and non-sterile liquids.

Tags: site us france market

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
18.06Potential Tropical Cyclone One Graphics
18.06Potential Tropical Cyclone One Public Advisory Number 3A
18.06Summary for Potential Tropical Cyclone One (AT1/AL012024)
18.06Post Office sabotaged Horizon probe, says investigator
18.06Atlantic Tropical Weather Outlook
18.06Eastern North Pacific Tropical Weather Outlook
18.06Farm Progress America, June 18, 2024
18.06Farm Progress America, June 18, 2024
More »